DatasetName,KIDINS220_S(1155) KIDINS220_S(1163) KIDINS220_S(1195) KIDINS220_S(1197) KIDINS220_S(1250) KIDINS220_S(1253) KIDINS220_S(131) KIDINS220_S(1329) KIDINS220_S(134) KIDINS220_S(1349) KIDINS220_S(1359) KIDINS220_S(1361) KIDINS220_S(1362) KIDINS220_S(1365) KIDINS220_S(137) KIDINS220_S(1382) KIDINS220_S(1385) KIDINS220_S(1388) KIDINS220_S(1422) KIDINS220_S(1427) KIDINS220_S(1452) KIDINS220_S(1456) KIDINS220_S(1471) KIDINS220_S(1502) KIDINS220_S(1507) KIDINS220_S(1518) KIDINS220_S(1521) KIDINS220_S(1524) KIDINS220_S(1526) KIDINS220_S(1531) KIDINS220_S(1536) KIDINS220_S(1540) KIDINS220_S(1544) KIDINS220_S(1549) KIDINS220_S(1554) KIDINS220_S(1555) KIDINS220_S(1559) KIDINS220_S(1574) KIDINS220_S(1575) KIDINS220_S(1582) KIDINS220_S(1593) KIDINS220_S(1594) KIDINS220_S(1598) KIDINS220_S(1602) KIDINS220_S(1604) KIDINS220_S(1614) KIDINS220_S(1621) KIDINS220_S(1623) KIDINS220_S(1633) KIDINS220_S(1642) KIDINS220_S(1643) KIDINS220_S(1662) KIDINS220_S(1679) KIDINS220_S(1681) KIDINS220_S(1717) KIDINS220_S(2) KIDINS220_S(843) KIDINS220_S(876) KIDINS220_S(882) KIDINS220_S(885) KIDINS220_S(894) KIDINS220_S(915) KIDINS220_S(918) KIDINS220_T(1458) KIDINS220_T(1477) KIDINS220_T(1515) KIDINS220_T(1528) KIDINS220_T(1580) KIDINS220_T(1660) KIDINS220_T(1665) KIDINS220_T(1679) KIDINS220_T(1682) KIDINS220_T(1684) KIDINS220_T(687) KIDINS220_T(915) KIDINS220_T(922) KIDINS220_Y(12) KIDINS220_Y(1473),KIDINS220_S(1342) KIDINS220_S(1343) KIDINS220_T(890)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.499443905610684,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.5050418416741304,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5033601974331572,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5004191499325732,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,0.5041864735086559,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5031851082733135,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5171859004670976,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5070394065790116,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5024742145343006,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.5023882518132129,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.5058515905960502,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.4997409201416986,
WZ2023_Pu_010_30min,0.5035386585514758,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5037887372351302,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,0.5046055983035297,
AH2018_TMTMS3_1_C,0.5027537672762116,
JJ2018_Ratio H/L normalized___1,0.5006361608645069,
ZQ2022_C2,0.5072506043308335,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.49605647792482616,
AH2018_SILAC_MR_2_N,0.500801563746185,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5073001034434098,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.5050878356062289,
UK2020_HCM_2,0.5004004765639714,
FSO2013_Ratio H/L normalized Rep2___2,0.5009910859906423,
EP2017_Pervanadate R#3 normalized log2 ratio,0.4999941643578707,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5053249016621406,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5034412533053871,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5036904495424698,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.502350851951861,
KBE2022_Log2_Ex_34_U,0.5026560625769795,
WZ2023_Pu_005_10min,0.5026972277321825,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.5001299504164216,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5032076583670791,
AH2018_SILAC_MR_2_X,0.5005154172571995,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5118417655400632,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.5004332604169459,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.49456753557062544,
JJ2018_Ratio M/L normalized pP3,0.5027352753272316,
AH2018_SILAC_M_2_N,0.5027858448444881,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.5024470678590847,
AH2018_LFQ_1_C,0.5008477663130181,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5034007423286783,
CK2022_11 40-1,0.4998767800470351,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5017389954570453,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5019519331714007,
FSO2013_Ratio H/L normalized Rep2,0.5050680842400271,
WZ2023_Pu_005_20min,0.5036720131083029,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5053485226238197,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5026262011273345,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,0.49724462349567855,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.5059646313003653,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5007736448883322,
CK2022_1 200-1,0.5026708875388746,
PG2020_Intensity Mock_10h_D,0.49836618741776617,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5009273288232126,
RCJD2014_5min_1,0.5012904537880305,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,0.5025454506384353,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.49877414831940886,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5033056029383544,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.5027119443451189,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5017233406463333,
CK2022_3 40-1,0.5001487532719832,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.5015921231476569,
ZQ2022_N2,0.4993913507570359,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,0.5068071737260409,
AH2018_TMTMS3_2_N,0.5052840593084971,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.4955215242524865,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5036275514157855,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5047134175092319,
HS2024_8_I_T3,,
CF2017_EOC 3,0.5026198082777166,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,0.5024109674453033,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,0.501998651969166,
WZ2023_Pu_010_20min,0.5032891326647866,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.500123701217725,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5034310104961262,
KS2014_Intensity N3,0.49881854643107587,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5028449645074512,
FSO2013_Ratio H/M normalized Rep2,0.5092740347795316,
RAM2015_Log2 A,0.5136342155539962,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,0.5012757070125559,
CF2017_OSE 27,0.502902627539837,
KS2014_Intensity E15_2,0.5031514583943585,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5015365582111654,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.49523378401930884,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5005512297596413,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.5023954769648422,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.4993027393246821,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.5023782671244833,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5019486650666,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.4977632108329395,
FSO2013_Ratio M/L normalized Rep2,0.5097069629272186,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5027623669791895,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.5005486288423341,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.49686377516156244,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.500610609394225,
DL2023_control-1,0.49996288102610964,
AR2021_ALG 10 μM,0.49550118571050017,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5035793049629496,
EJN2021_4_Rest_Ins,,
RN2012_H05,0.5039755059265268,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5020742376411286,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.5029183817796182,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5015778636716751,
JW2021_After_3,,
GF2025_P8_Sph,0.5069099144061904,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.5009738574108129,
AH2018_SILAC_2_N,0.5025343507178657,
CK2022_11 200-1,0.5006209004162501,
CK2022_12 200-1,0.4995480479903135,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5005320022788629,
WZ2023_Su_010_20min,0.5053068861101158,
AH2018_TMTMS2_2_N,0.5043989349105427,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5026306268229362,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5027373709178301,
KS2014_Intensity N4,0.49680950996822104,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5032022251015473,
CK2022_14 200-1,0.5006552170263732,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5015509547439478,
AST2020_anti-CD3+PDL2.2,0.5023967907744193,
PG2020_Intensity Mock_10h_A,0.495130714054948,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5000468046500417,
GF2025_P1_Adh,0.49916632770749647,
GF2025_P1_Sph,0.5058754665310153,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5030860099006608,
CF2017_EOC 1,0.5022235328387563,
CK2022_3 200-1,0.5028278819708393,
AH2018_LFQ_IT_3_C,0.5017224353108987,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.5021066769309992,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5042200124625664,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.49919254357420184,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.49968198528096636,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5026094568392008,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.503405752720371,
AR2021_ALG 1 μM,0.5047064420865234,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5038164964702614,
CR2017_Ratio Replicate 3.2,0.4958826064738355,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5086453112446288,
CK2022_9 16-1,0.49952844783832606,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5010926224687695,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5008140955985442,
CK2022_16 16-1,0.5006603637327677,
FS2019_db/db3,0.5032585288984067,
CK2022_15 40-1,0.5007393205938139,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5029891013740109,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5026189791690404,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5017237454927633,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5022865773399571,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.4951779264283692,
KBE2022_Log2_Ex_27_U,0.5023325042625568,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5031927242670557,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.4955117446385888,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.4992985018357169,
RN2012_L13,0.5038906982603413,
LG2023_Control-1_intensity,0.4981461159993813,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5085697252009203,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5001939744432998,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5064374785096536,
HH2022_Reporter intensity 6,0.5020367530352633,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.504528025771814,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5045446159936434,
GF2025_P3_Adh,0.5018048609561782,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5029284309655342,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.4988511103447372,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,0.5022014496440875,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5051799569758147,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5096437197751001,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.5015976053531157,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.5001968529029795,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5007761877946718,
HH2022_Reporter intensity 1,0.5026418032873801,
HH2022_Reporter intensity 2,0.5029461353312802,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.503011432233204,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5077982766199208,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5035234866523517,
AR2021_KD 72h,0.5023646025450119,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5024099410618259,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5056411065527568,
KBE2022_Log2_Ex_9_U,0.5022833205422299,
AH2018_SILAC_M_3_N,0.4960865098393337,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5004316394252957,
CF2017_OSE 29,0.5032291248289568,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,0.5028429678537503,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.500349675840956,
RN2012_L12,0.5026606861016307,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.49565787636334235,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.509640743930624,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.5045411053165056,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5017815284723807,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.5035416423660328,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.49376097180446676,
FSO2013_Ratio H/M normalized Rep2___2,0.505029987104532,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5026232706342705,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5034539709189287,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5076285039757266,
CK2022_5 200-1,0.5073583789351449,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5033232019263101,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.49977446309329593,
AH2018_SILAC_MR_1_X,0.5005296693850122,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5024124429652693,
AH2018_SILAC_3_C,0.49567816818879945,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5121262266508518,
CK2022_4 16-1,0.5000996059923615,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5009009837956407,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.49755957471958195,
JJ2018_Ratio M/L normalized pP2,0.5009710303278883,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5008679408583901,
FSO2013_Ratio H/L normalized Rep3,0.5088567384096054,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,0.5013234209446638,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.5024118795096469,
AH2018_SILAC_IT_2_N,0.5034469524100629,
AH2018_SILAC_IT_1_X,0.5015645326962814,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,0.5002002769202447,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5053032135018293,
WZ2023_Pe_025_20min,0.5022327787877432,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5003167622497026,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5055474074823879,
RN2012_H06,0.5028730956539245,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5033294512791056,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.5001262168377187,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.4837338672743245,
WZ2023_Su_025_10min,0.50209420673502,
AH2018_LFQ_IT_4_X,0.4945525600330619,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5029091483950353,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.5006782459804444,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.49993336536459326,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5048494898090373,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,0.4998637444942544,
EP2017_Untreated R#1 normalized log2 ratio,0.501638076127333,
RN2012_L10,0.5031447750966286,
PG2020_Intensity 4h_C,0.4938148559487807,
EP2017_Mitotic R#3 normalized log2 ratio,0.4998686165237336,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5024917278308189,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5016560702923432,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.5012626119900816,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5002995025070083,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5006247275848218,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.49943651290394736,
GF2025_P9_Sph,0.5050638696324432,
CK2022_6 200-1,0.5074024056552228,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5047445724852534,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.5004897218129793,
EP2017_Untreated R#3 normalized log2 ratio,0.5072868158298526,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5075313132759742,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.498071104336543,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5007469155748693,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5017321840769798,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.502780167784855,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5005530083225934,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5025507490869942,
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,0.5025808808526973,
KS2014_Intensity pY_PV4,0.5042589463127234,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.5066935929062968,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5039294032361007,
HS2024_8_PD_T2,,
FS2019_Ctr2,0.5016919146754515,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.4982872031658448,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5047651126350287,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5079004998399249,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,0.5058647882082616,
AH2018_LFQ_M_2_N,0.5029741692500911,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,0.5009248100227081,
RAM2015_Log2 B,0.5087464028967928,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.5167399407853812,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.5010130513098423,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,0.5001996976889107,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.4934321789337586,
WZ2023_Su_025_30min,0.5027677925527468,
AH2018_LFQ_4_N,0.49870813793102,
CR2017_Ratio Replicate 1.2,0.5057468507493418,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5022117387017625,
AH2018_SILAC_M_1_X,0.5026578472937507,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.5022430182048151,
LY2019_P6+,0.5027647234532886,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5036398609401446,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5027282126144056,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5040951118543754,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.503538970529585,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5017416974312509,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.49619639146415917,
AH2018_LFQ_2_X,0.49921093088876883,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5042595103644864,
GF2025_P3_Sph,0.506700286541844,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5004199726605797,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.5053760936676023,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5033626222316286,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.49575999247584296,
ZQ2022_N1,0.4993583124034177,
LY2019_P6-,0.49927009046705706,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.4998411453122816,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5036062116411454,
AH2018_LFQ_3_N,0.5015957042177248,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.5040334412767369,
UK2020_UA_1,0.4998662636564997,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.5006089208764477,
CK2022_7 40-1,0.5017229763618459,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5009159798769697,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.5006714019126454,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.5030312159718684,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5067225759194864,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5015495571182225,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5005059250481256,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5040855792922707,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.49972952619952393,
FSO2013_Ratio M/L normalized Rep1___3,0.5141058334238531,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.49913501256793996,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.500798734158415,
AH2018_LFQ_M_4_C,0.502525972527172,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,0.5029250791594583,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5030249358310465,
CK2022_6 40-1,0.5018870730780279,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.506609218590983,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5030307126399766,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,0.5021493591168441,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,0.5011488471688731,
WZ2023_Pu_025_20min,0.5037422449258118,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5070293768192108,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,0.5037092019702342,
AH2018_TMTMS2_2_C,0.5044915115519842,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5058535874709497,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5016859295628553,
LY2019_P8+,0.5066351644592378,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.5041760842652143,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5024223233988375,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5035524450065646,
LY2019_P2-,0.5090821016377852,
AH2018_LFQ_IT_1_X,0.5022792253162437,
JJ2018_Ratio H/L normalized pP3___1,0.5005152294763344,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5036527889107192,
AST2020_Control.2,0.5022719834268287,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.49835302581135066,
FSO2013_Ratio H/L normalized Rep2___3,0.5021690699113581,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5001893841540751,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5028443960706825,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.5024204242707401,
AH2018_TMTMS3_3_N,0.5051541453003012,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5005990791886678,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5002809030054023,
KBE2022_Log2_Ex_36_T,0.5025324572649853,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5026764691583485,
KS2014_Intensity C2,0.5026920237184128,
FSO2013_Ratio H/L normalized Rep1___2,0.5039146929327085,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.5008928567471295,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5013000849203431,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5031495781289472,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.4937754018963704,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5038488327212819,
ZQ2022_C3,0.5060045943488698,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,0.500493095875617,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5011682183528998,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5016884993508552,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5024362752407414,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.4972902191160452,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.5010159238338502,
AH2018_SILAC_MR_2_C,0.5017663911620701,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5010539846464795,
JJ2018_Ratio H/M normalized___1,0.5019337840907984,
RCJD2014_15min_2,0.5062657736662937,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.5030659931865902,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.49656982714976633,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.5022160917097158,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5039927688971807,
KBE2022_Log2_Ex_29_U,0.5030311260493576,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.5019542132637006,
AH2018_LFQ_IT_4_N,0.4955047260982552,
CK2022_15 200-1,0.5009044496361769,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.501943790728895,
JJ2018_Ratio M/L normalized pP3___1,0.502747802014726,
KBE2022_Log2_Ex_34_T,0.502661000511329,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.4969013086106642,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5022107320825376,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5030770592325976,
RN2012_H01,0.5040722208770474,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5001507697966235,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.5026830494148479,
WZ2023_Pe_010_20min,0.50428371481704,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5047445432555434,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5035262228627768,
KS2014_Intensity C1,0.4997638819580356,
FSO2013_Ratio H/M normalized Rep3___1,0.503934122036188,
AH2018_SILAC_M_3_C,0.49629884186791784,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5020063305503845,
AH2018_SILAC_M_2_X,0.5014861599971324,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5034796802657998,
PG2020_Intensity 6h_C,0.5007819415782808,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.5009693670661645,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5045230586907156,
CK2022_15 16-1,0.5002281537126522,
CK2022_3 16-1,0.500912988891466,
LY2019_P4-,0.5088869099276164,
FSO2013_Ratio H/L normalized Rep3___2,0.5010985323690552,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.502597203085302,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5027561534172208,
CK2022_10 16-1,0.4995754868341973,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.500344243383539,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.49922953388120067,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5031157113188944,
AR2021_L41 10 μM,0.5027506741961904,
CF2017_EOC 2,0.502341507310373,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.502849570018904,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.49988010260745414,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.5035011587699634,
ZX2022_CB treated Replicate 1,0.5036681424602278,
BS2014_Log2(Ratio H/L normalized Rep_3),0.5065032868229742,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5028877037030437,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5045018592491503,
AR2021_L41 1 μM,0.5018128479044025,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5036074610464318,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5033984240255597,
KS2014_Intensity C4,0.5022632872127656,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.502363536295204,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5006566775468303,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,0.5152077625256591,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5014480611970025,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,0.5076162371168038,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.502456445661373,
WZ2023_Pu_025_10min,0.5044497712930828,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.5075367971535804,
FSO2013_Ratio M/L normalized Rep3___1,0.504390680961661,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5031442502865812,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5038752947432306,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5025113259570084,
KS2014_Intensity C6,0.5033639066840272,
ZQ2022_N3,0.49878455855807174,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.49994543103679806,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5031973165660463,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.5008242699359311,
AH2018_SILAC_IT_2_C,0.5023015840596436,
CK2022_5 40-1,0.5017422567916975,
AH2018_LFQ_3_X,0.4998622831711906,
UK2020_UA_3,0.4998019024664133,
LY2019_P7-,0.505651333479041,
GF2025_P5_Adh,0.5000050999029821,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5064007524405191,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.4972841015869513,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.498518439755629,
ZQ2022_C1,0.5057908781359184,
CR2017_Ratio Replicate 2.1,0.5054355351558928,
PG2020_Intensity CT_B,0.5003957960365631,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5006707084119062,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,0.5030597749009953,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5035690152217593,
AH2018_LFQ_3_C,0.4983465617276525,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5018086792745176,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,0.49979639019173616,
GF2025_P4_Sph,0.5026130089299061,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.5024720896470354,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.5013198204996684,
FR2021_Intensity.H,,
CK2022_14 16-1,0.4999396143543686,
AST2020_anti-CD3+PDL2,0.502237642296573,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,0.5053080266040204,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5006371368942645,
AH2018_TMTMS2_1_X,0.5040301672664356,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,0.5023686558652594,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.4995713486679468,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5036490897853808,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.5022938338373516,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.5026429059702243,
CF2017_FTE 14,0.5040064563962723,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5015318185762601,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.5035057535925083,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5024490074638167,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5004656461252065,
AS2011_Ratio H/L Normalized RNAi_2_1,,
